Carle Foundation Hospital

Urbana, Illinois 74104

6 studies enrolling now · 70 studies all time

What they study most

Acute Coronary Syndrome, Aortic Aneurysm, Abdominal, Aortic Valve Stenosis, Atherosclerosis, Atrial Fibrillation, Blood Cancer, Breast Cancer, COVID-19, Cardiac Resynchronization Therapy, Cardiovascular Disease, Cardiovascular Diseases, Cellulitis

Studies at this site

• MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
• Fecal Microbiota Transplant National Registry — Recruiting now
• Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• TECTONIC CAD IVL IDE Study — Running, not enrolling
• STOP Persistent AF PAS — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
• Optimal Targeted High-definition Transcranial Direct Current Stimulation for Reducing Post-stroke Upper Limb Motor Impairments — Starting soon
• Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
• Pain Management for In-Office Gynecologic Procedures Using a Risk-Stratification Pain Calculator — Starting soon
• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation — Running, not enrolling
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
• IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact — Running, not enrolling
• Cryo Global Registry — Completed
• Hydroxyurea Optimization Through Precision Study — Completed
• A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort — Stopped early
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease — Completed
• Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation — Completed
• Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting — Enrolling by invitation
• Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) — Completed
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Running, not enrolling
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) — Completed
• Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral Revascularization — Completed
• RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction — Completed
• Confirmatory Clinical Study of Oxiplex — Completed
• A Pivotal Study of the Premia Spine TOPS™ System — Completed
• Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy — Completed
• ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 — Completed
• ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 — Completed
• Clinical Evaluation of the OtoSight — Completed
• Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis — Completed
• Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury — Completed
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — Stopped early
• Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome — Stopped early
• Phase 4 IOP Signals Associated With ILUVIEN® — Completed
• Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) — Completed
• Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study — Completed